Financial Performance - The company's operating revenue for Q1 2025 was ¥947,580,849.16, representing a 28.95% increase compared to ¥734,854,835.55 in the same period last year[2] - The net profit attributable to shareholders was -¥35,921,355.84, a decrease of 386.15% from -¥7,388,891.55 year-on-year[2] - Basic and diluted earnings per share were both -¥0.0542, reflecting a decrease of 383.93% compared to -¥0.0112 in the same period last year[2] - The net loss for Q1 2025 was ¥29,618,921.15, compared to a net profit of ¥2,068,894.14 in Q1 2024[18] - The operating profit for Q1 2025 was a loss of ¥38,527,114.02, down from a profit of ¥4,595,299.24 in Q1 2024[17] Cash Flow - The net cash flow from operating activities increased by 20.61% to ¥63,524,099.07 from ¥52,669,485.03 in the previous year[2] - In Q1 2025, the company reported cash inflows from operating activities of CNY 658,550,621.12, a 45.5% increase compared to CNY 452,623,677.40 in Q1 2024[19] - The net cash flow from operating activities for Q1 2025 was CNY 63,524,099.07, up from CNY 52,669,485.03 in Q1 2024, reflecting a growth of 20.5%[19] - Cash outflows for purchasing goods and services in Q1 2025 amounted to CNY 433,290,810.06, compared to CNY 252,913,806.78 in Q1 2024, indicating a significant increase of 71.3%[19] - The company experienced a net cash outflow from investing activities of CNY -3,794,070.70 in Q1 2025, an improvement from CNY -23,855,389.95 in Q1 2024[20] - Cash inflows from financing activities totaled CNY 104,452,065.00 in Q1 2025, compared to CNY 25,470,000.00 in Q1 2024, marking a substantial increase of 310.5%[20] - The net cash outflow from financing activities was CNY -137,595,339.78 in Q1 2025, worsening from CNY -110,033,483.44 in Q1 2024[20] - The ending cash and cash equivalents balance for Q1 2025 was CNY 253,486,331.36, down from CNY 586,099,752.25 in Q1 2024[20] - The company received CNY 10,000,000.00 from other financing activities in Q1 2025, which was not reported in Q1 2024[20] - The cash inflow from the disposal of fixed assets in Q1 2025 was CNY 3,384,375.00, compared to CNY 542,000.00 in Q1 2024, showing a significant increase[20] Assets and Liabilities - Total assets at the end of Q1 2025 were ¥5,240,026,201.03, down 3.60% from ¥5,435,872,214.93 at the end of the previous year[3] - The total liabilities as of the reporting date were ¥3,300,841,118.81, a slight decrease from ¥3,343,685,861.46 in the previous period[14] - The company's cash and cash equivalents decreased, impacting liquidity, with short-term borrowings rising to ¥234,891,271.57 from ¥183,548,579.32[14] - The equity attributable to shareholders decreased to ¥1,645,198,807.78 from ¥1,655,402,125.99, indicating a decline in shareholder value[14] Costs and Expenses - Total operating costs for Q1 2025 were ¥988,591,784.44, up 31.6% from ¥751,271,257.49 in Q1 2024[17] - The increase in costs due to rising prices of raw materials, particularly phosphorus ore, led to a significant decline in gross profit margins[4] - Research and development expenses increased to ¥3,273,980.24 in Q1 2025, compared to ¥981,170.60 in Q1 2024, reflecting a significant investment in innovation[17] - The company paid CNY 51,983,934.53 in taxes in Q1 2025, which is a 125.4% increase from CNY 23,039,281.35 in Q1 2024[19] Shareholder Information - The company registered a capital increase for its wholly-owned subsidiary, Shanghai Chengxing Phosphate Chemical Co., Ltd., from ¥500,000 to ¥20,000,000[9] - The company reported a total of 29,148 common shareholders at the end of the reporting period[6] - The top ten shareholders held a combined 52.63% of the company's shares, with the largest shareholder owning 25.78%[7]
ST澄星(600078) - 2025 Q1 - 季度财报